This study is testing whether adding a targeted dose of radiation to the breast tumor before starting standard chemotherapy and an immunotherapy drug (pembrolizumab) makes the treatment more effective. It is for people with breast cancer that has spread to lymph nodes and is eith…
Phase: PHASE2 • Sponsor: Laura M. Spring, MD • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC